Also trades as: PPBT.TA (TLV) · $vol 0M
PPBT NASDAQ
Purple Biotech Ltd.
1W: +0.0%
1M: -23.7%
3M: -12.7%
YTD: -77.1%
1Y: +157.7%
3Y: -93.4%
5Y: -98.4%
$1.51
-0.01 (-0.66%)
Weekly Expected Move ±9.6%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$18M
-52.6% ▼
5Y CAGR: -26.8%
Total Liabilities
$8M
+91.7% ▲
5Y CAGR: +14.3%
Shareholders Equity
$10M
-70.4% ▼
5Y CAGR: -34.3%
Cash & Investments
$10M
+12.3% ▲
5Y CAGR: -30.2%
Total Debt
$244K
+33.3% ▲
5Y CAGR: -22.9%
Net Debt
-$8M
-17.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $11M | $15M | $14M | $7M | $9M |
| Short-Term Investments | $36M | $17M | $923K | $1M | $857K |
| Cash & ST Investments | $47M | $32M | $15M | $9M | $10M |
| Net Receivables | $0 | $0 | $0 | $275K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $268K | $146K | $171K | $109K | $292K |
| Total Current Assets | $48M | $33M | $16M | $9M | $10M |
| Property, Plant & Equip. | $896K | $682K | $470K | $288K | $346K |
| Goodwill & Intangibles | $20M | $21M | $28M | $28M | $7M |
| Long-Term Investments | $187K | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $160K | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $22M | $21M | $29M | $28M | $8M |
| Total Assets | $70M | $55M | $44M | $37M | $18M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $2M | $4M | $1M | $2M |
| Short-Term Debt | $0 | $0 | $0 | $183K | $244K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $611K | $698K | $673K | $966K | $5M |
| Total Current Liabilities | $4M | $7M | $7M | $4M | $8M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $292K | $145K | $3M | $140K | $160K |
| Total Non-Current Liabilities | $842K | $466K | $3M | $140K | $160K |
| Total Liabilities | $5M | $8M | $10M | $4M | $8M |
| — Equity — | |||||
| Common Stock | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$96M | -$118M | -$137M | -$145M | -$171M |
| Accumulated OCI | $37M | $38M | -$79K | -$98K | $28M |
| Total Stockholders Equity | $65M | $47M | $34M | $33M | $10M |
| Total Liabilities & Equity | $70M | $55M | $44M | $37M | $18M |
| — Key Metrics — | |||||
| Total Debt | $749K | $515K | $351K | $183K | $244K |
| Net Debt | -$10M | -$15M | -$14M | -$7M | -$8M |
| Total Investments | $36M | $17M | $923K | $1M | $857K |